Observational studyInternal medicine (Tokyo, Japan)2017

Therapeutic Response to Twice-daily Rabeprazole on Health-related Quality of Life and Symptoms in Patients with Refractory Reflux Esophagitis: A Multicenter Observational Study.

Yoshikazu Kinoshita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.